Entyvio 300 mg powder for concentrate for solution for infusion
Vedolizumab-2005
Phase 2 small_molecule active
Quick answer
Entyvio 300 mg powder for concentrate for solution for infusion for Ulcerative Colitis or Crohn's Disease is a Phase 2 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Ulcerative Colitis or Crohn's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active